Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$42.43 - $70.83 $10.8 Million - $18 Million
-254,631 Reduced 19.53%
1,049,256 $71.4 Million
Q2 2024

Jul 29, 2024

BUY
$41.33 - $74.26 $8.62 Million - $15.5 Million
208,641 Added 19.05%
1,303,887 $55.1 Million
Q1 2024

Apr 29, 2024

BUY
$56.27 - $73.77 $11.8 Million - $15.4 Million
209,330 Added 23.63%
1,095,246 $75.6 Million
Q4 2023

Feb 07, 2024

SELL
$59.06 - $75.72 $8 Million - $10.3 Million
-135,406 Reduced 13.26%
885,916 $65.5 Million
Q3 2023

Nov 02, 2023

SELL
$65.94 - $99.04 $2.95 Million - $4.44 Million
-44,780 Reduced 4.2%
1,021,322 $69.7 Million
Q2 2023

Aug 07, 2023

BUY
$62.68 - $95.05 $2.87 Million - $4.35 Million
45,815 Added 4.49%
1,066,102 $100 Million
Q1 2023

May 09, 2023

BUY
$47.19 - $70.77 $7.24 Million - $10.9 Million
153,482 Added 17.71%
1,020,287 $69.2 Million
Q4 2022

Feb 09, 2023

BUY
$30.35 - $53.15 $25.1 Million - $43.9 Million
825,515 Added 1999.31%
866,805 $42.9 Million
Q3 2022

Nov 09, 2022

SELL
$31.97 - $49.37 $104,605 - $161,538
-3,272 Reduced 7.34%
41,290 $1.34 Million
Q2 2022

Aug 10, 2022

BUY
$35.61 - $76.23 $83,754 - $179,292
2,352 Added 5.57%
44,562 $1.76 Million
Q1 2022

May 09, 2022

SELL
$57.56 - $82.54 $104,989 - $150,552
-1,824 Reduced 4.14%
42,210 $2.95 Million
Q4 2021

Feb 09, 2022

SELL
$72.5 - $100.68 $950,402 - $1.32 Million
-13,109 Reduced 22.94%
44,034 $3.43 Million
Q3 2021

Nov 09, 2021

SELL
$90.24 - $124.05 $21.8 Million - $29.9 Million
-241,210 Reduced 80.85%
57,143 $5.45 Million
Q2 2021

Aug 10, 2021

SELL
$93.66 - $139.27 $5.88 Million - $8.75 Million
-62,808 Reduced 17.39%
298,353 $37.1 Million
Q1 2021

May 10, 2021

BUY
$116.57 - $155.01 $32.9 Million - $43.8 Million
282,651 Added 360.02%
361,161 $47.6 Million
Q4 2020

Feb 08, 2021

BUY
$99.61 - $142.12 $256,296 - $365,674
2,573 Added 3.39%
78,510 $10.4 Million
Q3 2020

Nov 06, 2020

BUY
$72.92 - $102.01 $1.29 Million - $1.8 Million
17,691 Added 30.37%
75,937 $7.74 Million
Q2 2020

Aug 05, 2020

BUY
$55.75 - $92.75 $1.04 Million - $1.73 Million
18,685 Added 47.23%
58,246 $5.06 Million
Q1 2020

May 12, 2020

SELL
$37.9 - $104.44 $65,680 - $180,994
-1,733 Reduced 4.2%
39,561 $2.29 Million
Q4 2019

Feb 05, 2020

BUY
$77.66 - $99.74 $235,698 - $302,710
3,035 Added 7.93%
41,294 $3.82 Million
Q3 2019

Nov 13, 2019

SELL
$90.37 - $122.49 $355,786 - $482,243
-3,937 Reduced 9.33%
38,259 $3.46 Million
Q2 2019

Aug 12, 2019

SELL
$89.51 - $118.04 $7.58 Million - $9.99 Million
-84,638 Reduced 66.73%
42,196 $4.98 Million
Q1 2019

May 10, 2019

BUY
$61.98 - $96.5 $415,142 - $646,357
6,698 Added 5.58%
126,834 $11 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $130,180 - $192,019
2,323 Added 1.97%
120,136 $7.58 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $693,492 - $1.16 Million
-14,361 Reduced 10.87%
117,813 $9.3 Million
Q2 2018

Aug 13, 2018

SELL
$37.84 - $69.96 $2.1 Million - $3.89 Million
-55,604 Reduced 29.61%
132,174 $0
Q1 2018

May 14, 2018

BUY
$39.82 - $57.53 $549,476 - $793,856
13,799 Added 7.93%
187,778 $7.57 Million
Q4 2017

Feb 13, 2018

BUY
$46.49 - $60.51 $2.39 Million - $3.11 Million
51,318 Added 41.84%
173,979 $9.14 Million
Q3 2017

Nov 02, 2017

BUY
$37.05 - $47.12 $4.54 Million - $5.78 Million
122,661
122,661 $5.78 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.